These results suggest that the combination of high glucose concentrations with osteogenic factors has a synergistic effect on Runx2 levels, determining a significant increase in the Runx2 expression (by 3.5-fold) as compared with OM (by 2.5-fold). The gene discussed is RUNX2; the disease is ocular melanoma.